Evidence map›Paper›PMID 41883838›Full record

ArticleJournal of blood medicine2026

Joint Damage Prediction in Non-Severe Hemophilia A with Artificial Intelligence.

Ana Marco-Rico, José Manuel Calvo-Villas, Francisco-Jose Lopez-Jaime, Mariana Canaro Hirnyk, María Del Mar Nieto-Hernández, Sonia Herrero Martín, Laura Entrena-Ureña, Shally Marcellini-Antonio, Bolivar L Diaz-Jordan, Sergio Jurado-Herrera and 6 more

Abstract read
In one paragraph

Article in Journal of blood medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ana Marco-RicoDepartment of Hematology and Hemotherapy, Dr. Balmis General University Hospital-ISABIAL, Alicante, Spain.ORCID 0000-0002-7971-6591
José Manuel Calvo-VillasDepartment of Hematology and Hemotherapy, Miguel Servet University Hospital, Zaragoza, Spain.
Francisco-Jose Lopez-JaimeDepartment of Hematology and Hemotherapy, Málaga Regional University Hospital-IBIMA, Málaga, Spain.
Mariana Canaro HirnykDepartment of Hematology and Hemotherapy, Son Espases University Hospital, Palma de Mallorca, Spain.
María Del Mar Nieto-HernándezDepartment of Hematology and Hemotherapy, Jaén University Hospital, Jaén, Spain.
Sonia Herrero MartínDepartment of Hematology and Hemotherapy, Guadalajara University Hospital, Guadalajara, Spain.
Laura Entrena-UreñaDepartment of Hematology and Hemotherapy, Virgen de Las Nieves University Hospital, Granada, Spain.
Shally Marcellini-AntonioDepartment of Hematology and Hemotherapy, Segovia General Hospital, Segovia, Spain.
Bolivar L Diaz-JordanDepartment of Hematology and Hemotherapy, Valdepeñas General Hospital, Ciudad Real, Spain.ORCID 0009-0006-7783-7951
Sergio Jurado-HerreraDepartment of Hematology and Hemotherapy, Torrecárdenas University Hospital, Almería, Spain.ORCID 0009-0005-4700-4214
Noelia F Pérez-GonzálezDepartment of Hematology and Hemotherapy, Torrecárdenas University Hospital, Almería, Spain.
Covadonga García-DíazDepartment of Hematology and Hemotherapy, Burgos University Hospital, Burgos, Spain.
Faustino García-CandelDepartment of Hematology and Hemotherapy, Virgen de la Arrixaca University Hospital, Murcia, Spain.
Ihosvany Fernández-BelloDepartment of Hematology and Hemotherapy, Dr. Balmis General University Hospital-ISABIAL, Alicante, Spain.ORCID 0000-0001-7822-8900
Jorge Mateo-SotosMedical Analysis Expert Group, Castilla-La Mancha University, Cuenca, Spain.
Pascual Marco-VeraDepartment of Hematology and Hemotherapy, Dr. Balmis General University Hospital-ISABIAL, Alicante, Spain.ORCID 0000-0002-3412-7566

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Patients with non-severe hemophilia A (PwnSHA) can develop joint damage (JD). The objective was to identify a machine learning model based on routinely collected variables to predict the presence of JD in PwnSHA. Patients and Methods: A nationwide, multicenter, cross-sectional study was conducted. Clinical and laboratory variables to assess joint health were included. Predictors were age, target joint history, thrombin generation capacity, baseline factor VIII (FVIII) measured by one-stage clotting (FVIII-CLOT) and chromogenic (FVIII-CHR) assays, and the FVIII-CLOT/FVIII-CHR ratio. The joint condition was described using the HEAD-US score. JD was defined as HEAD-US >0. A Random Forest (RF) ensemble was trained with regression-based multiple imputation, z-scaling, and Synthetic Minority Oversampling within a stratified five-fold stratified cross-validation repeated 100 times. Support Vector Machine, Decision Tree, Gaussian Naïve Bayes and k-Nearest Neighbors were used as comparators. Model performance was assessed on held-out test folds, and 95% confidence intervals (CIs) were obtained by bootstrap resampling with 10,000 repetitions. Results: Eighty-four Spanish males ≥12 years old were enrolled. Forty-two percent (35/84) had JD. JD was present in 30% (3/10) of patients with moderate hemophilia and 43% (32/74) with mild hemophilia. The RF achieved an accuracy of 92.0% (95% CI: 90.72-93.31), a recall of 92.1% (95% CI: 90.87-93.41), a specificity of 91.9% (95% CI: 90.58-93.27), and an AUC-ROC of 0.92 (95% CI: 0.907-0.938), outperforming all alternative classifiers. Permutation-based feature importance identified age, target joint history, thrombin generation and the FVIII-CLOT/FVIII-CHR ratio as the most influential variables. Conclusion: The RF model identifies PwnSHA more likely to have prevalent, occult JD in a cross-sectional setting, enabling rapid triage for targeted HEAD-US evaluation. External and prospective validation in larger cohorts is now warranted to confirm generalizability and to facilitate integration into electronic health-record decision-support systems aimed at preserving long-term joint health in PwnSHA.

Indexed as

joint damagemachine learningnon-severe hemophilia arandom forestthrombin generation

Identifiers

PMID41883838
PMCPMC13011837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.